Sammenlign metoder

	Asthma Control Test	EORTC QLQ-C30
Fagområde	Sundhedsudfald	Sundhedsudfald
Familie	Process / pipeline	Process / pipeline
Oprindelsesår	2004	1993
Ophavsperson	Robert A. Nathan et al.	Nico Aaronson et al.
Type	Self-report symptom control questionnaire	Self-report quality of life questionnaire
Oprindelig kilde	Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., ... & Pendergraft, T. B. (2004). Development of the asthma control test: A survey for assessing asthma control in children and adults. Allergy and Asthma Proceedings, 25(1), 1-6.	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.
Aliasser	ACT, Asthma Control Test, Asthma Control Assessment	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
Relaterede	4	5
Resumé	The ACT is a simple, rapid, patient-centered measure of asthma control. Developed by Robert Nathan and colleagues in 2004, this 5-item questionnaire quantifies how asthma symptoms, activity limitation, and nighttime awakening affect daily life. It is the most widely used asthma control measure in clinical practice and is recommended by major asthma guidelines as a standard assessment tool.	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.